Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients.
about
Potential Biomarkers of Fat Loss as a Feature of Cancer CachexiaContribution of Neuroinflammation to the Pathogenesis of Cancer CachexiaEnergy balance and metabolism after cancer treatmentCancer cachexia: impact, mechanisms and emerging treatmentsTumor macroenvironment and metabolism.Proinflammatory cytokines and the hypermetabolism of children with sickle cell diseaseTocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancerCancer cachexia, mechanism and treatmentSerum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.The impact of baseline serum C-reactive protein and C-reactive protein kinetics on the prognosis of metastatic nasopharyngeal carcinoma patients treated with palliative chemotherapyNutritional interventions for cancer-induced cachexiaGut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target.Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review.Metabolism in patients with small cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls.Elevated serum C-reactive protein as a prognostic marker in small cell lung cancerProtein and energy depletion in chronic hemodialysis patients: clinical applicability of diagnostic tools.The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma.Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy--a longitudinal study.The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancerDo patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?Prognostic value of serial serum interleukin-6 level estimation in patients with lung cancer: a preliminary report.Energy metabolism and nutritional status in hospitalized patients with lung cancerTumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity.The role of triglyceride lipases in cancer associated cachexia.The role of inflammatory pathways in cancer-associated cachexia and radiation resistance.Novel investigational biologics for the treatment of cancer cachexia.Phase II drugs that are currently in development for the treatment of cachexia.A role of active brown adipose tissue in cancer cachexia?Effect of pre existing respiratory conditions on survival of lung cancer patients: A nationwide population-based cohort study.Impact of cachexia on outcomes in aggressive lymphomas.Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.Effect of proinflammatory interleukins on jejunal nutrient transport.Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status.Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo.Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor.Down-regulation of glutathione and Bcl-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium.Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin.Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients.
P2860
Q26778319-C1D1B986-2601-4D2D-A953-527C00B83907Q26778695-73A78AC5-8367-4F91-B4A9-63829271A2CBQ27015118-C1E23839-313C-4067-B4A9-6651E8CCAA4EQ28384479-9D74D2A8-F97A-4044-ADD1-23861DEA0BE0Q33574461-18214EF0-8835-4322-9241-C2A98DC94E0CQ33662087-B28BCA3A-9B72-4912-99EA-F6DDB35C404AQ33882832-62523CFF-8B20-478B-B18E-65224F462C67Q34669440-2AB361A0-B519-45CB-B1EC-FF0022BCE993Q35011366-8D0FA300-983A-4E15-998F-88EAD06B7A12Q35018650-C64B986F-B41B-4E5A-8B1E-963F00A85493Q35019743-766A41C7-02EF-40E3-8E5E-1E69CE03F63FQ35025946-08C4DC26-459A-46BF-8788-9F3C31430963Q35200370-A04F7540-FEF8-440A-8079-CDE63F5573EFQ35563502-D723B368-2CAF-4D97-9C3C-236304346578Q35648199-53992EA0-D5B9-4E78-BD9A-76C0D4374B2BQ36278331-FF2EAE68-3591-43F5-83E0-26F20853FB82Q36431605-8341B743-0E64-41FD-A980-25A052CACB22Q36616257-CB3BA7B7-8DC6-4D53-BFA8-94A416F8AC72Q36623998-DC9E9FEA-791D-4923-9B43-BB005FBCA7A6Q36648454-FD410C8F-E3BA-4178-9CA1-5EAB3F0E4DD6Q36694116-2C208768-EC55-453D-8B64-0A329FFA3EEFQ36987729-787B7D4D-1288-4427-B805-D080BB45D1D1Q37247027-F77BDD13-6198-41D5-8C14-DFB06B5037EDQ37409946-9F73A636-D464-45CD-95F9-44DEF2820A4BQ38090208-02258AA8-1829-4A16-B0C5-641D878EFA03Q38115997-89A10A37-C8D3-4874-B9DD-F8CA304C28B3Q38202666-1ACB2DD3-B651-4396-B1D0-8AC17130155DQ38233278-786E4E4F-C17F-46DD-9B77-9AA22058B56CQ38493100-48280987-7233-4654-A743-6F4F4ADA16ABQ38649697-DAD1E03B-0514-48C6-A284-BE233B354E9EQ38833394-2402FCA5-51F0-48EE-94C9-3E5E98FBC8BDQ40433122-5DA717A2-989F-4BBD-995A-C4F8C0DE0003Q42259565-268F00E0-34D7-49E9-970C-BFFC065A4FC0Q42370649-7F24041D-4442-47AE-9F42-BF9E4ABFD4A5Q42987057-ACD39F57-5752-41F6-9494-13B752A876C0Q43668998-201A9D97-5496-427D-9EB9-9BFA1A7B4CFDQ43762936-1193E21A-61B8-4E56-8DD7-0D26E2AD0525Q44526097-5CCE60B2-FC62-4377-B777-89DDEDE1B906Q46990341-BFDFA7EB-1752-4FE1-85B6-FE92826838A8Q47231376-1BBCCBFF-C203-48BE-A4F7-8247C64A70A8
P2860
Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Increased resting energy expen ...... ponse in lung cancer patients.
@en
Increased resting energy expen ...... ponse in lung cancer patients.
@nl
type
label
Increased resting energy expen ...... ponse in lung cancer patients.
@en
Increased resting energy expen ...... ponse in lung cancer patients.
@nl
prefLabel
Increased resting energy expen ...... ponse in lung cancer patients.
@en
Increased resting energy expen ...... ponse in lung cancer patients.
@nl
P2093
P1476
Increased resting energy expen ...... ponse in lung cancer patients.
@en
P2093
A J Staal-van den Brekel
A M Schols
E F Wouters
M A Dentener
W A Buurman
P304
P356
10.1200/JCO.1995.13.10.2600
P407
P577
1995-10-01T00:00:00Z